Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-05

Clinical Trial Update: Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of diacerein on metabolic control in adults with type 2 diabetes and metformin resistance; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diacerein (Diacerein)

Snippet

Sponsor: ANS Pharma | Conditions: Complications of Diabetes Mellitus, Diabetes Mellitus | Phase 2 | Status: COMPLETED